The United States Percutaneous Coronary Interventions (PCI) Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook (2019-2022)

September 2022
The USA Percutaneous Coronary Interventions (PCI) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with more than 100 performing physicians in Interventional Cardiology departments from Academic Hospitals, Community Hospitals, Office Based Labs (OBL), and Private Hospitals in the USA.

The report covers:

  • Diagnostic Procedures: diagnostic intracoronary imaging and monitoring procedures
  • Percutaneous Coronary Interventional Procedures: chronic total occlusion (CTO) procedures
  • Intracoronary Imaging Modalities: intravascular ultrasound (IVUS), optical coherence tomography (OCT)
  • Interventional Measurement Approaches: fractional flow reserve (FFR) & instantaneous wave free ratio (iFR)
  • Percutaneous Coronary Interventions: coronary stents, coronary angioplasty balloons, coronary atherectomy devices, embolic protection devices are covered in detail.
  • Procedure Trends: by facility type, approach, and modality/device type.

“I use both antegrade and retrograde, it all depends on the extent of the blockage, how long of a blockage it is, and how many collaterals there are distal. Then, I also look at the tip of the blockage to see whether there is a break or not. If there is a side branch in the side, I use both retrograde and antegrade.”

– Interventional Cardiologist, USA 2020

  • >80% of intracoronary imaging procedures are performed with IVUS
  • >50% of CTO procedures are performed through the antegrade approach
  • >50% of atherectomy procedures use rotational atherectomy
  • Physicians’ brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others effecting brand usage have been covered.
  • Future Trends for PCI treatment landscape show that advances in percutaneous coronary intervention techniques such as intravascular lithotripsy is expected to impact angioplasty and stenting procedures. Orbital atherectomy is expected to gain traction as it is easier to set up and use compared with other atherectomy techniques.
  • Competitor landscape covered the following company activities in addition to many more in the report – Cardiovascular Systems Inc. completed a feasibility study for intravascular lithotripsy (IVL) for coronary artery disease (CAD) and peripheral artery disease (PAD), and the company has plans to start enrollment of patients in an investigational device exemption (IDE) study for coronary IVL system in 2023. Teleflex received FDA approval for an expanded indication for specialty catheters and guidewires for use in chronic total occlusion (CTO).

What’s in it for you?

  • This report will help percutaneous coronary interventional (PCI) devices companies understand the percutaneous coronary interventional landscape, procedural and technology trends, the brand perception, and competitor activities in the USA.
  • The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the percutaneous coronary interventional devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
Contact us below for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.

    Drop Us A Line

    We provide the best insights for your business